BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32400971)

  • 1. MAPT haplotype-stratified GWAS reveals differential association for AD risk variants.
    Strickland SL; Reddy JS; Allen M; N'songo A; Burgess JD; Corda MM; Ballard T; Wang X; Carrasquillo MM; Biernacka JM; Jenkins GD; Mukherjee S; Boehme K; Crane P; Kauwe JS; Ertekin-Taner N;
    Alzheimers Dement; 2020 Jul; 16(7):983-1002. PubMed ID: 32400971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels.
    Allen M; Kachadoorian M; Quicksall Z; Zou F; Chai HS; Younkin C; Crook JE; Pankratz VS; Carrasquillo MM; Krishnan S; Nguyen T; Ma L; Malphrus K; Lincoln S; Bisceglio G; Kolbert CP; Jen J; Mukherjee S; Kauwe JK; Crane PK; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Schellenberg GD; Parisi JE; Petersen RC; Graff-Radford NR; Dickson DW; Younkin SG; Ertekin-Taner N
    Alzheimers Res Ther; 2014; 6(4):39. PubMed ID: 25324900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural study of the microtubule-associated protein tau locus of Alzheimer's disease in Taiwan.
    Chang CW; Hsu WC; Pittman A; Wu YR; Hardy J; Fung HC
    Biomed J; 2014; 37(3):127-32. PubMed ID: 24923570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders.
    Lai MC; Bechy AL; Denk F; Collins E; Gavriliouk M; Zaugg JB; Ryan BJ; Wade-Martins R; Caffrey TM
    Mol Neurodegener; 2017 Oct; 12(1):79. PubMed ID: 29084565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.
    Pastor P; Moreno F; Clarimón J; Ruiz A; Combarros O; Calero M; López de Munain A; Bullido MJ; de Pancorbo MM; Carro E; Antonell A; Coto E; Ortega-Cubero S; Hernandez I; Tárraga L; Boada M; Lleó A; Dols-Icardo O; Kulisevsky J; Vázquez-Higuera JL; Infante J; Rábano A; Fernández-Blázquez MÁ; Valentí M; Indakoetxea B; Barandiarán M; Gorostidi A; Frank-García A; Sastre I; Lorenzo E; Pastor MA; Elcoroaristizabal X; Lennarz M; Maier W; Rámirez A; Serrano-Ríos M; Lee SE; Sánchez-Juan P;
    J Alzheimers Dis; 2016; 49(2):343-52. PubMed ID: 26444794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.
    Gerrish A; Russo G; Richards A; Moskvina V; Ivanov D; Harold D; Sims R; Abraham R; Hollingworth P; Chapman J; Hamshere M; Pahwa JS; Dowzell K; Williams A; Jones N; Thomas C; Stretton A; Morgan AR; Lovestone S; Powell J; Proitsi P; Lupton MK; Brayne C; Rubinsztein DC; Gill M; Lawlor B; Lynch A; Morgan K; Brown KS; Passmore PA; Craig D; McGuinness B; Todd S; Johnston JA; Holmes C; Mann D; Smith AD; Love S; Kehoe PG; Hardy J; Mead S; Fox N; Rossor M; Collinge J; Maier W; Jessen F; Kölsch H; Heun R; Schürmann B; van den Bussche H; Heuser I; Kornhuber J; Wiltfang J; Dichgans M; Frölich L; Hampel H; Hüll M; Rujescu D; Goate AM; Kauwe JS; Cruchaga C; Nowotny P; Morris JC; Mayo K; Livingston G; Bass NJ; Gurling H; McQuillin A; Gwilliam R; Deloukas P; Davies G; Harris SE; Starr JM; Deary IJ; Al-Chalabi A; Shaw CE; Tsolaki M; Singleton AB; Guerreiro R; Mühleisen TW; Nöthen MM; Moebus S; Jöckel KH; Klopp N; Wichmann HE; Carrasquillo MM; Pankratz VS; Younkin SG; Jones L; Holmans PA; O'Donovan MC; Owen MJ; Williams J
    J Alzheimers Dis; 2012; 28(2):377-87. PubMed ID: 22027014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study.
    Valentino RR; Scotton WJ; Roemer SF; Lashley T; Heckman MG; Shoai M; Martinez-Carrasco A; Tamvaka N; Walton RL; Baker MC; Macpherson HL; Real R; Soto-Beasley AI; Mok K; Revesz T; Christopher EA; DeTure M; Seeley WW; Lee EB; Frosch MP; Molina-Porcel L; Gefen T; Redding-Ochoa J; Ghetti B; Robinson AC; Kobylecki C; Rowe JB; Beach TG; Teich AF; Keith JL; Bodi I; Halliday GM; Gearing M; Arzberger T; Morris CM; White CL; Mechawar N; Boluda S; MacKenzie IR; McLean C; Cykowski MD; Wang SJ; Graff C; Nagra RM; Kovacs GG; Giaccone G; Neumann M; Ang LC; Carvalho A; Morris HR; Rademakers R; Hardy JA; Dickson DW; Rohrer JD; Ross OA;
    Lancet Neurol; 2024 May; 23(5):487-499. PubMed ID: 38631765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotype-specific expression of exon 10 at the human MAPT locus.
    Caffrey TM; Joachim C; Paracchini S; Esiri MM; Wade-Martins R
    Hum Mol Genet; 2006 Dec; 15(24):3529-37. PubMed ID: 17085483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of MAPT haplotype-tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: A preliminary study in a Croatian cohort.
    Babić Leko M; Willumsen N; Nikolac Perković M; Klepac N; Borovečki F; Hof PR; Sonicki Z; Pivac N; de Silva R; Šimić G
    Brain Behav; 2018 Nov; 8(11):e01128. PubMed ID: 30329219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcript Variants of Genes Involved in Neurodegeneration Are Differentially Regulated by the APOE and MAPT Haplotypes.
    Koks S; Pfaff AL; Bubb VJ; Quinn JP
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association study stratified by
    Senkevich K; Bandres-Ciga S; Cisterna-García A; Yu E; Bustos BI; Krohn L; Lubbe SJ; Botía JA; ; Gan-Or Z
    medRxiv; 2023 Apr; ():. PubMed ID: 37292720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.
    Kwok JB; Loy CT; Hamilton G; Lau E; Hallupp M; Williams J; Owen MJ; Broe GA; Tang N; Lam L; Powell JF; Lovestone S; Schofield PR
    Ann Neurol; 2008 Oct; 64(4):446-54. PubMed ID: 18991351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue.
    Tauber CV; Schwarz SC; Rösler TW; Arzberger T; Gentleman S; Windl O; Krumbiegel M; Reis A; Ruf VC; Herms J; Höglinger GU
    Acta Neuropathol Commun; 2023 Mar; 11(1):40. PubMed ID: 36906636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H1/H2 MAPT haplotype and Parkinson's disease in Mexican mestizo population.
    Miranda-Morales EG; Sandoval-Carrillo A; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Quiñones-Canales G; Ruano-Calderón LA; Arias-Carrión O; Salas-Pacheco JM
    Neurosci Lett; 2019 Jan; 690():210-213. PubMed ID: 30339920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
    Pittman AM; Myers AJ; Abou-Sleiman P; Fung HC; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris CM; Dickson D; Wood NW; Hardy J; Lees AJ; de Silva R
    J Med Genet; 2005 Nov; 42(11):837-46. PubMed ID: 15792962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onset.
    Okunoye O; Ojo OO; Abiodun O; Abubakar S; Achoru C; Adeniji O; Agabi O; Agulanna U; Akinyemi R; Ali M; Ani-Osheku I; Arigbodi O; Bello A; Erameh C; Farombi T; Fawale M; Imarhiagbe F; Iwuozo E; Komolafe M; Nwani P; Nwazor E; Nyandaiti Y; Obiabo Y; Odeniyi O; Odiase F; Ojini F; Onwuegbuzie G; Osaigbovo G; Osemwegie N; Oshinaike O; Otubogun F; Oyakhire S; Ozomma S; Samuel S; Taiwo F; Wahab K; Zubair Y; Hernandez D; Bandres-Ciga S; Blauwendraat C; Singleton A; Houlden H; Hardy J; Rizig M; Okubadejo N
    Parkinsonism Relat Disord; 2023 Aug; 113():105517. PubMed ID: 37467655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau haplotypes and ApoE4 do not act in synergy on Alzheimer's disease.
    Almos PZ; Horváth S; Czibula A; Raskó I; Domján N; Juhász A; Janka Z; Kálmán J
    Psychiatry Res; 2011 Apr; 186(2-3):448-50. PubMed ID: 20837363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.
    Zhang CC; Zhu JX; Wan Y; Tan L; Wang HF; Yu JT; Tan L
    Oncotarget; 2017 Jul; 8(27):44994-45007. PubMed ID: 28402959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.
    Vandrovcova J; Pittman AM; Malzer E; Abou-Sleiman PM; Lees AJ; Wood NW; de Silva R
    Neurobiol Aging; 2009 Sep; 30(9):1477-82. PubMed ID: 18162161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An association study of common variation at the MAPT locus with late-onset Alzheimer's disease.
    Abraham R; Sims R; Carroll L; Hollingworth P; O'Donovan MC; Williams J; Owen MJ
    Am J Med Genet B Neuropsychiatr Genet; 2009 Dec; 150B(8):1152-5. PubMed ID: 19308965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.